Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ:OABI)

1.822 +0.112 (+6.56%)
Streaming Delayed Price Updated: 2:58 PM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about OmniAb, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model. 
Via Investor's Business Daily
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks You'll Regret Missing This Quarter ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Recap: OmniAb Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview For OmniAb ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 18, 2025 ↗
 
Via Benzinga
News headline image
OABI Stock Earnings: OmniAb Beats EPS, Beats Revenue for Q2 2024 ↗
OABI stock results show that OmniAb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
OABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024 ↗
OABI stock results show that OmniAb missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying ↗
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023 ↗
OABI stock results show that OmniAb beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 20, 2024 ↗
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. 
Via Benzinga
News headline image
Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight ↗
While you can likely achieve a higher degree of success with blue chips, for blistering gains, turn to powerful small-cap stocks. 
Via InvestorPlace
News headline image
7 of the Best Cheap Stocks to Buy Under $5 in October 2023 ↗
While the concept is incredibly risky, those who want to give their portfolio a jolt should consider these best cheap stocks. 
Via InvestorPlace
News headline image
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
7 Stocks to Buy for 200% Returns This Year ↗
These high return stock investments all have the potential to triple in 2023 based on Wall Street expectations. 
Via InvestorPlace
News headline image
Earnings Scheduled For August 10, 2023 ↗
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
News headline image
7 Stocks to Buy for Their Massive Upside Potential ↗
While blue chips are relatively predictable, they’re also boring. For serious gains, you need to check out these stocks to buy now. 
Via InvestorPlace
News headline image
Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
$1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed higher on Monday after recording losses last week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
News headline image
7 Biotech Stocks With Huge Return Potential for Long-Term Investors ↗
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023 ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.